financetom
Business
financetom
/
Business
/
Twitter, Elon Musk head to October trial over $44 billion deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Twitter, Elon Musk head to October trial over $44 billion deal
Jul 19, 2022 1:37 PM

An epic legal fight between Elon Musk and Twitter began in earnest in a Delaware court on Tuesday as lawyers for both sides fought over how soon the trial should begin.

Share Market Live

NSE

Twitter is trying to force the billionaire to make good on his April promise to buy the social media giant for $44 billion and the company wants it to happen quickly because it says the ongoing dispute is harming its business.

Musk, the world's richest man, pledged to pay $54.20 a share for Twitter, but now wants to back out of the agreement. It's attempted sabotage. He's doing his best to run Twitter down, said attorney William Savitt, representing Twitter in Delaware's Court of Chancery before the court's Chancellor Kathaleen St. Jude McCormick.

Also Read:

New Tesla plants are money furnaces losing billions, says Elon Musk

The hearing was held virtually after McCormick said she tested positive for COVID-19. Musk has claimed the company has failed to provide adequate information about the number of fake, or spam bot, Twitter accounts, and that it has breached its obligations under the deal by firing top managers and laying off a significant number of employees.

But the idea the Tesla CEO is trying to damage Twitter is preposterous. He has no interest in damaging the company, said Musk's attorney Andrew Rossman, noting he is Twitter's second-largest shareholder with a far larger stake than the entire board.

Savitt emphasised the importance of an expedited trial starting in September for Twitter to be able to make important business decisions affecting everything from employee retention to relationships with suppliers and customers.

Also Read: Elon Musk’s father, Errol Musk, confirms secret second love child with stepdaughter

Rossman said more time is needed because it is one of the largest take-private deals in history involving a company that has a massive amount of data that has to be analysed. Billions of actions on their platform have to be analysed.

First Published:Jul 19, 2022 10:37 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marchex Joining Microsoft's Cloud AI Partner Program
Marchex Joining Microsoft's Cloud AI Partner Program
Dec 11, 2024
09:33 AM EST, 12/11/2024 (MT Newswires) -- Marchex ( MCHX ) said Wednesday it has signed an agreement to join Microsoft's ( MSFT ) Cloud AI Partner Program. The move will give Marchex ( MCHX ) the ability to transact via Microsoft's ( MSFT ) Azure Marketplace, which will connect clients to its products, the company said. The products will...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely detailed plans...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK, Dec 11 (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely...
Copyright 2023-2026 - www.financetom.com All Rights Reserved